Mastering the World of Work for Mental Illness
Trial Summary
What is the purpose of this trial?
The purpose of this study is to conduct a randomized clinical trial for an innovative intervention entitled "Mastering the World of Work" (MWW). MWW aims to improve the employment outcomes of individuals with psychiatric disabilities who experience metacognitive deficits. Metacognitive deficits are represented in diminished capacity to form an integrated sense of self and others and respond to challenges in life. The randomized trial (N=60) will be conducted with recipients of Supported Employment (Individual Placement and Support) services at the Mental Health Center of Greater Manchester, in Manchester, NH. Given COVID-19 safety considerations, the MWW intervention will be delivered in a hybrid manner depending on the preferences of both clinicians and clients at the MHCGM at any given point of the study. The feasibility of remote delivery of the intervention has been established as part of a pilot study conducted at BU CPR. Thus, clinicians may deliver the intervention using HIPAA-complaint ZOOM connection and/or in person. The assessments will be administered at baseline, 6, 12, and 18 months post baseline remotely by BU staff using a HIPAA-complaint ZOOM connection. The RCT will establish preliminary evidence about the incremental effectiveness of the MWW intervention to improve the employment outcomes of individuals with metacognitive deficits who receive high fidelity IPS services. Study participants randomized to the control condition will receive IPS services as usual.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment Mastering the World of Work (MWW) for mental illness?
Research shows that work therapy can be a useful part of treatment for people with chronic mental illness, helping them engage in active and social life, which is important for recovery. Employment is linked to self-respect and recovery, and programs like Individual Placement and Support (IPS) are recognized as effective in vocational rehabilitation.12345
How is the treatment Mastering the World of Work (MWW) unique for mental illness?
Mastering the World of Work (MWW) is unique because it focuses on helping individuals with mental illness gain and retain employment, which is an important part of recovery. Unlike other treatments that may focus solely on symptoms, MWW addresses the social and professional aspects of living with mental illness, providing support for work integration and employment.678910
Research Team
Zlatka Russinova, PhD
Principal Investigator
Boston University Center for Psychiatric Rehabilitation
Eligibility Criteria
This trial is for English-speaking adults over 18 with serious mental illness, including dual diagnosis, who are unemployed but receiving Supported Employment services in Manchester, NH. Participants must be willing to engage via Zoom and consent to audio recordings of sessions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the MWW intervention, consisting of 29 sessions over 7 modules, delivered in a hybrid manner based on preferences and safety considerations.
Follow-up
Participants are monitored for employment outcomes and metacognitive capacity through assessments at baseline, 6, 12, and 18 months.
Treatment Details
Interventions
- Mastering the World of Work (MWW)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor